PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10848104

The continuing search for proper perspective: whose reasonableness should be at issue in a prescription product design defect analysis?

R L Cupp
View original source ↗Export metadata ↓

Abstract

This Article is based on a presentation given at Seton Hall University School of Law's Seventh Annual Health Law Symposium on February 12, 1999.

Explore related subjects

Congresses as TopicConsumer Product SafetyDecision MakingDrug DesignDrug PrescriptionsHumansLegislation, DrugLiteratureNew JerseyPharmaceutical PreparationsUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R L Cupp. 1999. The continuing search for proper perspective: whose reasonableness should be at issue in a prescription product design defect analysis?. https://pubmed.ncbi.nlm.nih.gov/10848104/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

On-demand therapy for gastroesophageal reflux disease.

The following pages summarize the proceedings of a symposium held in May 2006 on the emerging role of on-demand therapy for gastroesophageal reflux disease (GERD). Medical therapy for GERD has undergone significant change in recent years with the advent of effective, but expensive, antisecretory agents. On-demand (patient-driven) therapy is attractive to payers and patients, because it appears to be both cost-effective and convenient. Many individuals appear to accept occasional symptomatic breakthrough in exchange for personal control of their disease. On-demand therapy should be distinguished from intermittent therapy, which is either patient- or physician-driven, but which requires intermittent episodes of continuous therapy followed by discontinuation until symptoms recur. Proton pump inhibitors appear to be effective on-demand agents despite theoretical pharmacodynamic limitations for this class of drug. The available data support the use of on-demand therapy for GERD in uninvestigated reflux disease, nonerosive reflux disease, and possibly mild esophagitis as well. On-demand therapy should not be considered for patients with severe esophagitis.

Congresses as Topic↗